Advertisement
Canada markets closed
  • S&P/TSX

    24,439.08
    -32.09 (-0.13%)
     
  • S&P 500

    5,815.26
    -44.59 (-0.76%)
     
  • DOW

    42,740.42
    -324.80 (-0.75%)
     
  • CAD/USD

    0.7254
    -0.0007 (-0.10%)
     
  • CRUDE OIL

    70.84
    +0.26 (+0.37%)
     
  • Bitcoin CAD

    92,201.66
    +1,253.98 (+1.38%)
     
  • XRP CAD

    0.75
    -0.01 (-1.32%)
     
  • GOLD FUTURES

    2,675.20
    -3.70 (-0.14%)
     
  • RUSSELL 2000

    2,249.82
    +1.18 (+0.05%)
     
  • 10-Yr Bond

    4.0380
    -0.0600 (-1.46%)
     
  • NASDAQ futures

    20,360.25
    +18.25 (+0.09%)
     
  • VOLATILITY

    20.64
    +0.94 (+4.77%)
     
  • FTSE

    8,249.28
    -43.38 (-0.52%)
     
  • NIKKEI 225

    39,306.15
    -604.40 (-1.51%)
     
  • CAD/EUR

    0.6660
    -0.0003 (-0.05%)
     

With 80% institutional ownership, Health Catalyst, Inc. (NASDAQ:HCAT) is a favorite amongst the big guns

Key Insights

  • Given the large stake in the stock by institutions, Health Catalyst's stock price might be vulnerable to their trading decisions

  • A total of 11 investors have a majority stake in the company with 50% ownership

  • Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock

Every investor in Health Catalyst, Inc. (NASDAQ:HCAT) should be aware of the most powerful shareholder groups. With 80% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.

In the chart below, we zoom in on the different ownership groups of Health Catalyst.

See our latest analysis for Health Catalyst

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Health Catalyst?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

We can see that Health Catalyst does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Health Catalyst, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
earnings-and-revenue-growth

Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. It would appear that 6.8% of Health Catalyst shares are controlled by hedge funds. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. Looking at our data, we can see that the largest shareholder is The Vanguard Group, Inc. with 11% of shares outstanding. With 9.2% and 6.8% of the shares outstanding respectively, BlackRock, Inc. and Point72 Asset Management, L.P. are the second and third largest shareholders. Additionally, the company's CEO Daniel Burton directly holds 1.4% of the total shares outstanding.

A closer look at our ownership figures suggests that the top 11 shareholders have a combined ownership of 50% implying that no single shareholder has a majority.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of Health Catalyst

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

We can see that insiders own shares in Health Catalyst, Inc.. It has a market capitalization of just US$564m, and insiders have US$15m worth of shares, in their own names. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying.

General Public Ownership

The general public-- including retail investors -- own 10% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Health Catalyst better, we need to consider many other factors. Be aware that Health Catalyst is showing 2 warning signs in our investment analysis , you should know about...

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.